Overview
- Bayer aims to settle thousands of US glyphosate lawsuits in Missouri, where most cases are concentrated, while preparing for a possible Chapter 11 bankruptcy for Monsanto if talks fail.
- The legal disputes stem from allegations that Monsanto's herbicide, Roundup, causes cancer, despite regulatory approvals deeming it safe in over 20 countries, including the US and EU.
- Bayer has spent over €10 billion on settlements and legal costs since acquiring Monsanto in 2018, with more than 65,000 cases still unresolved.
- The company has enlisted restructuring advisors from Latham & Watkins and AlixPartners to explore options, including bankruptcy protections under US law.
- Heightened scrutiny from US Health Secretary Robert F. Kennedy Jr. and a pending Supreme Court decision on glyphosate warning labels add uncertainty to Bayer's legal and operational future.